News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Iroko Pharmaceuticals Acquires iCeutica Inc. to Bolster Capabilities in Novel Low-Dose NSAIDs


4/28/2011 9:01:39 AM

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC today announces that it has acquired iCeutica, Inc. to further strengthen Iroko’s position as the leading developer of novel, low-dose non-steroidal anti-inflammatory drugs (NSAIDs).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES